Status:
UNKNOWN
A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries
Lead Sponsor:
Ruijin Hospital
Conditions:
Urological Surgeries
Eligibility:
All Genders
Brief Summary
Study name：A Real-World Study to Evaluate the Clinical Performance and Safety of da Vinci SP Surgical System for Single-Port Urological Surgeries； Study purpose：This clinical trial is a real-world st...
Eligibility Criteria
Inclusion
- Subjects should meet all the following criteria:
- Subjects who have received or plan to receive RP, PN, RN, radical resection of the renal pelvic carcinoma (one position), pyeloplasty and other single-port urological robotic surgeries with the SP single-port robot;
- Patients who voluntarily decide to participate in the study and sign the ICF (or exempt from signature of the ICF as approved by the EC).
Exclusion
- The subjects meeting any of the following criteria should be excluded.
- Patients with missing data on the primary endpoint in retrospective cases;
- Subjects having any contraindications of single-port robot surgery;
- The intraoperative anatomy determined that minimally invasive surgery was not suitable;
- Patients who are considered inappropriate to participate in this Study by investigators.
Key Trial Info
Start Date :
February 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06181942
Start Date
February 22 2023
End Date
December 31 2024
Last Update
December 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China